Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 727-731, 2003; 10.1373/49.5.727
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (55)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, E. K.O.
Right arrow Articles by Lo, Y.M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, E. K.O.
Right arrow Articles by Lo, Y.M. D.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Pediatric Clinical Chemistry
(Clinical Chemistry. 2003;49:727-731.)
© 2003 American Association for Clinical Chemistry, Inc.

The Concentration of Circulating Corticotropin-releasing Hormone mRNA in Maternal Plasma Is Increased in Preeclampsia

Enders K.O. Ng1, Tse N. Leung2, Nancy B.Y. Tsui1, Tze K. Lau2, Nirmal S. Panesar1, Rossa W.K. Chiu1 and Y.M. Dennis Lo1,a

Departments of
1 Chemical Pathology and
2 Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR.

aAuthor for correspondence. Fax 852-2194-6171; e-mail loym{at}cuhk.edu.hk.

Background: Increased fetal DNA in maternal plasma/serum has been reported in pregnancies complicated by preeclampsia. We hypothesize that fetal RNA may also be increased in maternal plasma in preeclampsia.

Methods: We developed a real-time quantitative reverse transcription-PCR assay to measure the concentration of the mRNA of the corticotropin-releasing hormone (CRH) locus. Peripheral blood samples were obtained from healthy pregnant women both before and 2 h after delivery. Peripheral blood samples were also obtained from women suffering from preeclampsia and controls matched for gestational age. Plasma was harvested from these samples, and RNA was extracted. Plasma RNA was subjected to analysis by the reverse transcription-PCR assay.

Results: CRH mRNA was detected in the plasma of 10 healthy pregnant women in the third trimester. CRH mRNA was found to be cleared very rapidly after cesarean section, with no detectable signal by 2 h postpartum. Plasma CRH mRNA concentrations were 1070 and 102 copies/mL, respectively, in 12 preeclamptic women and 10 healthy pregnant women matched for gestational age (Mann–Whitney test, P <0.001).

Conclusion: Plasma CRH mRNA represents a new molecular marker for preeclampsia. Maternal plasma RNA is gender- and polymorphism-independent and may allow noninvasive gene-expression profiling of an unborn fetus.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
S. S.C. Chim, T. K.F. Shing, E. C.W. Hung, T.-y. Leung, T.-k. Lau, R. W.K. Chiu, and Y.M. Dennis Lo
Detection and Characterization of Placental MicroRNAs in Maternal Plasma
Clin. Chem., March 1, 2008; 54(3): 482 - 490.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Purwosunu, A. Sekizawa, K. Koide, A. Farina, N. Wibowo, G. H. Wiknjosastro, S. Okazaki, H. Chiba, and T. Okai
Cell-Free mRNA Concentrations of Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator Are Increased in the Plasma of Pregnant Women with Preeclampsia
Clin. Chem., March 1, 2007; 53(3): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S Okazaki, A Sekizawa, Y Purwosunu, M Iwasaki, A Farina, and T Okai
Measurement of mRNA of trophoblast-specific genes in cellular and plasma components of maternal blood.
J. Med. Genet., September 1, 2006; 43(9): e47 - e47.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. W.K. Chiu, W.-b. Lui, M.-c. Cheung, N. Kumta, A. Farina, I. Banzola, S. Grotti, N. Rizzo, C. J. Haines, and Y.M. D. Lo
Time Profile of Appearance and Disappearance of Circulating Placenta-Derived mRNA in Maternal Plasma
Clin. Chem., February 1, 2006; 52(2): 313 - 316.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. C.K. Wong, R. W.K. Chiu, N. B.Y. Tsui, K.C. A. Chan, L. W. Chan, T. K. Lau, T. N. Leung, and Y.M. D. Lo
Circulating Placental RNA in Maternal Plasma Is Associated with a Preponderance of 5' mRNA Fragments: Implications for Noninvasive Prenatal Diagnosis and Monitoring
Clin. Chem., October 1, 2005; 51(10): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
X. Y. Zhong, S. Gebhardt, R. Hillermann, K. C. Tofa, W. Holzgreve, and S. Hahn
Parallel Assessment of Circulatory Fetal DNA and Corticotropin-Releasing Hormone mRNA in Early- and Late-Onset Preeclampsia
Clin. Chem., September 1, 2005; 51(9): 1730 - 1733.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
G. T.Y. Chung, R. W.K. Chiu, K.C. A. Chan, T. K. Lau, T. N. Leung, L. W. Chan, and Y.M. D. Lo
Detrimental Effect of Formaldehyde on Plasma RNA Detection
Clin. Chem., June 1, 2005; 51(6): 1074 - 1076.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y.M. D. Lo
Recent Advances in Fetal Nucleic Acids in Maternal Plasma
J. Histochem. Cytochem., March 1, 2005; 53(3): 293 - 296.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
X. Y. Zhong, W. Holzgreve, I. Hoesli, and S. Hahn
Circulatory Corticotropin-Releasing Hormone mRNA Concentrations Are Increased in Women with Preterm Delivery But Not in Those Who Respond to Tocolytic Treatment
Clin. Chem., March 1, 2005; 51(3): 635 - 636.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. K. R. Chinnapapagari, W. Holzgreve, O. Lapaire, B. Zimmermann, and S. Hahn
Treatment of Maternal Blood Samples with Formaldehyde Does Not Alter the Proportion of Circulatory Fetal Nucleic Acids (DNA and mRNA) in Maternal Plasma
Clin. Chem., March 1, 2005; 51(3): 652 - 655.
[Full Text] [PDF]


Home page
JAMAHome page
P. B. Larrabee, K. L. Johnson, C. Lai, J. Ordovas, J. M. Cowan, U. Tantravahi, and D. W. Bianchi
Global Gene Expression Analysis of the Living Human Fetus Using Cell-Free Messenger RNA in Amniotic Fluid
JAMA, February 16, 2005; 293(7): 836 - 842.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Farina, N. Rizzo, M. Concu, I. Banzola, A. Sekizawa, S. Grotti, and P. Carinci
Lower Maternal PLAC1 mRNA in Pregnancies Complicated with Vaginal Bleeding (Threatened Abortion <20 Weeks) and a Surviving Fetus
Clin. Chem., January 1, 2005; 51(1): 224 - 227.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. K. Gupta, W. Holzgreve, B. Huppertz, A. Malek, H. Schneider, and S. Hahn
Detection of Fetal DNA and RNA in Placenta-Derived Syncytiotrophoblast Microparticles Generated in Vitro
Clin. Chem., November 1, 2004; 50(11): 2187 - 2190.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Farina, C. W.M. Chan, R. W.K. Chiu, N. B.Y. Tsui, P. Carinci, M. Concu, I. Banzola, N. Rizzo, and Y.M. D. Lo
Circulating Corticotropin-Releasing Hormone mRNA in Maternal Plasma: Relationship with Gestational Age and Severity of Preeclampsia
Clin. Chem., October 1, 2004; 50(10): 1851 - 1854.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
E. K.O. Ng, A. El-Sheikhah, R. W.K. Chiu, K.C. A. Chan, M. Hogg, R. Bindra, T. N. Leung, T. K. Lau, K. H. Nicolaides, and Y.M. D. Lo
Evaluation of Human Chorionic Gonadotropin {beta}-Subunit mRNA Concentrations in Maternal Serum in Aneuploid Pregnancies: A Feasibility Study
Clin. Chem., June 1, 2004; 50(6): 1055 - 1057.
[Full Text] [PDF]


Home page
J. Med. Genet.Home page
N B Y Tsui, S S C Chim, R W K Chiu, T K Lau, E K O Ng, T N Leung, Y K Tong, K C A Chan, and Y M D Lo
Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling
J. Med. Genet., June 1, 2004; 41(6): 461 - 467.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Wataganara, E. S. LeShane, A. Y. Chen, L. Borgatta, I. Peter, K. L. Johnson, and D. W. Bianchi
Plasma {gamma}-Globin Gene Expression Suggests that Fetal Hematopoietic Cells Contribute to the Pool of Circulating Cell-Free Fetal Nucleic Acids during Pregnancy
Clin. Chem., April 1, 2004; 50(4): 689 - 693.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. H. Rainer, N. Y.L. Lam, N. B.Y. Tsui, E. K.O. Ng, R. W.K. Chiu, G. M. Joynt, and Y.M. D. Lo
Effects of Filtration on Glyceraldehyde-3-Phosphate Dehydrogenase mRNA in the Plasma of Trauma Patients and Healthy Individuals
Clin. Chem., January 1, 2004; 50(1): 206 - 208.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Y.L. Lam, T. H. Rainer, R. W.K. Chiu, G. M. Joynt, and Y.M. D. Lo
Plasma Mitochondrial DNA Concentrations after Trauma
Clin. Chem., January 1, 2004; 50(1): 213 - 216.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C. B.M. Oudejans, A. T.J.J. Go, A. Visser, M. A.M. Mulders, B. A. Westerman, M. A. Blankenstein, and J. M.G. van Vugt
Detection of Chromosome 21-encoded mRNA of Placental Origin in Maternal Plasma
Clin. Chem., September 1, 2003; 49(9): 1445 - 1449.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.